Correlation Between FitLife Brands, and Summit Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FitLife Brands, and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FitLife Brands, and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FitLife Brands, Common and Summit Therapeutics PLC, you can compare the effects of market volatilities on FitLife Brands, and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FitLife Brands, with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of FitLife Brands, and Summit Therapeutics.

Diversification Opportunities for FitLife Brands, and Summit Therapeutics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between FitLife and Summit is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding FitLife Brands, Common and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and FitLife Brands, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FitLife Brands, Common are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of FitLife Brands, i.e., FitLife Brands, and Summit Therapeutics go up and down completely randomly.

Pair Corralation between FitLife Brands, and Summit Therapeutics

Given the investment horizon of 90 days FitLife Brands, is expected to generate 6.47 times less return on investment than Summit Therapeutics. But when comparing it to its historical volatility, FitLife Brands, Common is 6.76 times less risky than Summit Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Summit Therapeutics PLC is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  384.00  in Summit Therapeutics PLC on October 2, 2024 and sell it today you would earn a total of  1,405  from holding Summit Therapeutics PLC or generate 365.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

FitLife Brands, Common  vs.  Summit Therapeutics PLC

 Performance 
       Timeline  
FitLife Brands, Common 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in FitLife Brands, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable essential indicators, FitLife Brands, is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.
Summit Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Summit Therapeutics is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

FitLife Brands, and Summit Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FitLife Brands, and Summit Therapeutics

The main advantage of trading using opposite FitLife Brands, and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FitLife Brands, position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.
The idea behind FitLife Brands, Common and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Valuation
Check real value of public entities based on technical and fundamental data